AGRX
Agile Therapeutics
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
47 hedge funds and large institutions have $111M invested in Agile Therapeutics in 2017 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
15% more funds holding
Funds holding: 41 → 47 (+6)
Holders
47
Holding in Top 10
4
Calls
$57K
Puts
–
Top Buyers
| 1 | +$3.75M | |
| 2 | +$1.97M | |
| 3 | +$1.62M | |
| 4 |
DM
Deerfield Management
New York
|
+$1.19M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
+$943K |
Top Sellers
| 1 | -$4.66M | |
| 2 | -$309K | |
| 3 | -$211K | |
| 4 |
ECM
Element Capital Management
New York
|
-$208K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$185K |